The Emerson Group adds Oystershell Consumer Health and RID brand to portfolio

Print Friendly, PDF & Email

WAYNE, Pa. — The Emerson Group has added Oystershell Consumer Health, makers of the RID brand of lice treatment to its family of products. Emerson CPG Equity Management will be responsible for brand management, creative execution, and day-to-day operations of the RID brand. The Emerson Group will manage all sales activity for the RID brand across all U.S. retailers and Emerson Logistics will handle order processing, shipping, and financial reconciliation.

The RID brand is a leader in lice treatment and protection. The company offers a full range of products for lice treatment, Super Lice removal, or controlling lice at home.  “RID was the first lice brand launched in the U.S and has led in innovation for over 60 years. We look forward to bringing new innovation to our retailer partners under the RID brand,” said Ed Morgan, president, The Emerson Group.

“Oystershell is the global leader in Lice R&D technology. We are excited to bring our innovative formulations to the RID brand in the U.S. market to better serve consumers in this important category.” Partnering with The Emerson Group will drive the brand to new heights as we bring new growth opportunities to retailers through innovation and enhanced marketing support,” said Jeff Vernimb, president, Oystershell U.S.

Roger Gravitte, COO, The Emerson Group added: “We are excited to announce the Emerson CPG Equity Management division with the addition of the RID brand. This capability provides our partner companies with full Operating capabilities including Brand Management and Financial Reporting allowing for a more efficient business operating model for brands and companies.”


Adheris Health

Comments are closed.

Adheris Health